BSX - CIK 0000885725
The table below shows BOSTON SCIENTIFIC CORP's cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | $4.53B | $3.44B | $2.50B | $1.53B | $1.87B | $1.51B |
| Capital expenditure | $876.00M | $790.00M | $711.00M | $588.00M | $554.00M | $376.00M |
| Investing cash flow | -$2.64B | -$5.69B | -$2.57B | -$2.01B | -$1.60B | -$411.00M |
| Dividends paid | - | $0.00 | $28.00M | $55.00M | $55.00M |
BOSTON SCIENTIFIC CORP reported operating cash flow of $4.53B for fiscal year 2025. That is up 32.0% from $3.44B in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $1.18B (FY 2016) to $4.53B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $28.00M |
| Stock buybacks | - | - | - | $0.00 | $0.00 | $535.00M |
| Financing cash flow | -$395.00M | $1.81B | $5.00M | -$548.00M | -$95.00M | $293.00M |